US Stock MarketDetailed Quotes

HAE Haemonetics

Watchlist
  • 62.360
  • +0.070+0.11%
Close Feb 14 16:00 ET
  • 62.360
  • 0.0000.00%
Post 17:01 ET
3.13BMarket Cap24.55P/E (TTM)

Haemonetics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 28, 2024
(Q2)Sep 28, 2024
(Q1)Jun 29, 2024
(FY)Mar 30, 2024
(Q4)Mar 30, 2024
(Q3)Dec 30, 2023
(Q2)Sep 30, 2023
(Q1)Jul 1, 2023
(FY)Apr 1, 2023
(Q4)Apr 1, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
8,204.81%43.77M
-50.75%48.82M
-243.67%-27.42M
-33.44%181.75M
-19.51%64.08M
-100.84%-540K
13.88%99.12M
-54.55%19.09M
273.06M
79.61M
Net income from continuing operations
20.02%37.49M
35.82%33.83M
-6.50%38.37M
1.87%117.56M
-30.68%20.37M
-5.17%31.24M
-24.97%24.91M
106.48%41.04M
--115.4M
--29.38M
Operating gains losses
21.18%-160K
47.39%-121K
-6,578.04%-14.29M
-423.56%-2M
---1.35M
---203K
---230K
---214K
---382K
----
Depreciation and amortization
23.35%29.03M
26.96%29.22M
26.50%29.14M
4.19%97.22M
15.87%27.64M
-0.17%23.53M
-1.80%23.01M
2.61%23.03M
--93.31M
--23.85M
Deferred tax
25.52%-2.42M
----
----
-330.80%-11.04M
---5.9M
---3.25M
----
----
--4.78M
----
Other non cash items
90.60%6.93M
2,546.49%10.19M
-638.12%-9.29M
-12.34%6.66M
-85.68%907K
20.55%3.64M
110.27%385K
-13.22%1.73M
--7.59M
--6.33M
Change In working capital
54.47%-30.54M
-194.80%-29.84M
-59.72%-82.58M
-392.91%-74.7M
59.68%12.59M
-1,351.89%-67.06M
13.29%31.47M
-832.61%-51.7M
--25.5M
--7.89M
-Change in receivables
94.21%-1.77M
-618.57%-9.58M
689.11%7.97M
0.93%-24.19M
7,060.78%3.55M
-317.63%-30.6M
106.74%1.85M
-90.25%1.01M
---24.42M
---51K
-Change in inventory
-24.63%-12.55M
-953.42%-13.25M
-35.49%-39.83M
-295.29%-60.06M
-415.46%-19.34M
-578.37%-10.07M
-106.06%-1.26M
-292.89%-29.4M
--30.75M
---3.75M
-Change in prepaid assets
-59.22%1.08M
-177.33%-6.94M
102.07%3.22M
-158.23%-983K
-862.06%-2.71M
1,606.29%2.64M
-9,362.96%-2.5M
-24.69%1.6M
--1.69M
---282K
-Change in payables and accrued expense
113.96%3.31M
-88.19%3.98M
-195.47%-44.11M
11.97%44.58M
109.47%49.52M
-424.40%-23.7M
-6.54%33.69M
45.08%-14.93M
--39.82M
--23.64M
-Change in other working capital
-286.69%-20.6M
-1,228.20%-4.05M
1.47%-9.84M
-52.44%-34.05M
-57.90%-18.43M
-81.22%-5.33M
81.46%-305K
-64.27%-9.99M
---22.33M
---11.67M
Cash from discontinued investing activities
Operating cash flow
8,204.81%43.77M
-50.75%48.82M
-243.67%-27.42M
-33.44%181.75M
-19.51%64.08M
-100.84%-540K
13.88%99.12M
-54.55%19.09M
--273.06M
--79.61M
Investing cash flow
Cash flow from continuing investing activities
93.54%-17.37M
7.03%-23.37M
-812.11%-139.2M
-124.21%-322.39M
27.49%-13.06M
-636.81%-268.94M
19.10%-25.14M
73.78%-15.26M
-143.79M
-18.01M
Capital expenditure reported
41.65%-8.55M
-3.51%-9.43M
26.36%-5.66M
39.84%-66.3M
-192.44%-34.86M
13.07%-14.65M
74.66%-9.11M
83.11%-7.68M
---110.19M
---11.92M
Net PPE purchase and sale
-25.74%251K
-63.58%189K
4,965.17%20.36M
12.56%1.81M
109.05%551K
113.92%338K
-92.63%519K
-19.28%402K
--1.61M
---6.09M
Net business purchase and sale
--0
---1.76M
---149.15M
-12,017.60%-242.35M
--1.5M
---243.85M
--0
--0
---2M
--0
Net investment purchase and sale
----
----
90.98%-541K
53.17%-15.55M
----
----
----
42.28%-6M
---33.21M
--0
Net other investing changes
15.78%-9.08M
42.73%-12.91M
-112.46%-4.21M
----
----
---10.78M
---22.54M
---1.98M
----
----
Cash from discontinued investing activities
Investing cash flow
93.54%-17.37M
7.03%-23.37M
-812.11%-139.2M
-124.21%-322.39M
27.49%-13.06M
-636.81%-268.94M
19.10%-25.14M
73.78%-15.26M
---143.79M
---18.01M
Financing cash flow
Cash flow from continuing financing activities
-98.74%1.38M
-943.00%-74.8M
55,901.34%333.69M
138.02%38.16M
-3,861.45%-63.5M
320.27%109.43M
72.08%-7.17M
97.44%-598K
-100.36M
-1.6M
Net issuance payments of debt
-101.47%-1.56M
--0
25,839.26%450.44M
492.21%37.75M
-3,528.57%-63.5M
305.80%106.5M
-107.25%-3.5M
60.00%-1.75M
---9.63M
---1.75M
Net common stock issuance
--0
----
----
--0
--0
--0
----
----
---75M
--0
Proceeds from stock option exercised by employees
7.51%3.09M
105.64%207K
-365.41%-5.35M
2.82%7.21M
3,667.92%5.99M
38.29%2.88M
-267.29%-3.67M
-22.08%2.02M
--7.02M
--159K
Net other financing activities
-375.93%-149K
-120.00%-11K
-12,808.11%-111.4M
70.09%-6.81M
-49,841.67%-5.99M
700.00%54K
99.56%-5K
96.01%-863K
---22.76M
---12K
Cash from discontinued financing activities
Financing cash flow
-98.74%1.38M
-943.00%-74.8M
55,901.34%333.69M
138.02%38.16M
-3,861.45%-63.5M
320.27%109.43M
72.08%-7.17M
97.44%-598K
---100.36M
---1.6M
Net cash flow
Beginning cash position
-14.74%299.28M
20.55%344.43M
-37.15%178.8M
9.62%284.47M
-13.40%193.98M
45.52%351.01M
32.92%285.72M
9.62%284.47M
--259.5M
--224M
Current changes in cash
117.35%27.78M
-173.86%-49.35M
5,077.38%167.07M
-454.53%-102.48M
-120.79%-12.48M
-635.35%-160.05M
120.63%66.82M
108.15%3.23M
--28.91M
--60M
Effect of exchange rate changes
-305.63%-6.21M
374.46%4.2M
26.80%-1.45M
19.08%-3.19M
-684.63%-2.7M
-33.85%3.02M
62.04%-1.53M
59.98%-1.97M
---3.94M
--462K
End cash Position
65.40%320.85M
-14.74%299.28M
20.55%344.43M
-37.15%178.8M
-37.15%178.8M
-13.40%193.98M
45.52%351.01M
32.92%285.72M
--284.47M
--284.47M
Free cash flow
331.92%35.22M
-56.24%39.39M
-390.02%-33.08M
-29.11%115.46M
-56.83%29.23M
-131.93%-15.19M
76.21%90.01M
428.30%11.41M
--162.87M
--67.69M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Dec 28, 2024(Q2)Sep 28, 2024(Q1)Jun 29, 2024(FY)Mar 30, 2024(Q4)Mar 30, 2024(Q3)Dec 30, 2023(Q2)Sep 30, 2023(Q1)Jul 1, 2023(FY)Apr 1, 2023(Q4)Apr 1, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 8,204.81%43.77M-50.75%48.82M-243.67%-27.42M-33.44%181.75M-19.51%64.08M-100.84%-540K13.88%99.12M-54.55%19.09M273.06M79.61M
Net income from continuing operations 20.02%37.49M35.82%33.83M-6.50%38.37M1.87%117.56M-30.68%20.37M-5.17%31.24M-24.97%24.91M106.48%41.04M--115.4M--29.38M
Operating gains losses 21.18%-160K47.39%-121K-6,578.04%-14.29M-423.56%-2M---1.35M---203K---230K---214K---382K----
Depreciation and amortization 23.35%29.03M26.96%29.22M26.50%29.14M4.19%97.22M15.87%27.64M-0.17%23.53M-1.80%23.01M2.61%23.03M--93.31M--23.85M
Deferred tax 25.52%-2.42M---------330.80%-11.04M---5.9M---3.25M----------4.78M----
Other non cash items 90.60%6.93M2,546.49%10.19M-638.12%-9.29M-12.34%6.66M-85.68%907K20.55%3.64M110.27%385K-13.22%1.73M--7.59M--6.33M
Change In working capital 54.47%-30.54M-194.80%-29.84M-59.72%-82.58M-392.91%-74.7M59.68%12.59M-1,351.89%-67.06M13.29%31.47M-832.61%-51.7M--25.5M--7.89M
-Change in receivables 94.21%-1.77M-618.57%-9.58M689.11%7.97M0.93%-24.19M7,060.78%3.55M-317.63%-30.6M106.74%1.85M-90.25%1.01M---24.42M---51K
-Change in inventory -24.63%-12.55M-953.42%-13.25M-35.49%-39.83M-295.29%-60.06M-415.46%-19.34M-578.37%-10.07M-106.06%-1.26M-292.89%-29.4M--30.75M---3.75M
-Change in prepaid assets -59.22%1.08M-177.33%-6.94M102.07%3.22M-158.23%-983K-862.06%-2.71M1,606.29%2.64M-9,362.96%-2.5M-24.69%1.6M--1.69M---282K
-Change in payables and accrued expense 113.96%3.31M-88.19%3.98M-195.47%-44.11M11.97%44.58M109.47%49.52M-424.40%-23.7M-6.54%33.69M45.08%-14.93M--39.82M--23.64M
-Change in other working capital -286.69%-20.6M-1,228.20%-4.05M1.47%-9.84M-52.44%-34.05M-57.90%-18.43M-81.22%-5.33M81.46%-305K-64.27%-9.99M---22.33M---11.67M
Cash from discontinued investing activities
Operating cash flow 8,204.81%43.77M-50.75%48.82M-243.67%-27.42M-33.44%181.75M-19.51%64.08M-100.84%-540K13.88%99.12M-54.55%19.09M--273.06M--79.61M
Investing cash flow
Cash flow from continuing investing activities 93.54%-17.37M7.03%-23.37M-812.11%-139.2M-124.21%-322.39M27.49%-13.06M-636.81%-268.94M19.10%-25.14M73.78%-15.26M-143.79M-18.01M
Capital expenditure reported 41.65%-8.55M-3.51%-9.43M26.36%-5.66M39.84%-66.3M-192.44%-34.86M13.07%-14.65M74.66%-9.11M83.11%-7.68M---110.19M---11.92M
Net PPE purchase and sale -25.74%251K-63.58%189K4,965.17%20.36M12.56%1.81M109.05%551K113.92%338K-92.63%519K-19.28%402K--1.61M---6.09M
Net business purchase and sale --0---1.76M---149.15M-12,017.60%-242.35M--1.5M---243.85M--0--0---2M--0
Net investment purchase and sale --------90.98%-541K53.17%-15.55M------------42.28%-6M---33.21M--0
Net other investing changes 15.78%-9.08M42.73%-12.91M-112.46%-4.21M-----------10.78M---22.54M---1.98M--------
Cash from discontinued investing activities
Investing cash flow 93.54%-17.37M7.03%-23.37M-812.11%-139.2M-124.21%-322.39M27.49%-13.06M-636.81%-268.94M19.10%-25.14M73.78%-15.26M---143.79M---18.01M
Financing cash flow
Cash flow from continuing financing activities -98.74%1.38M-943.00%-74.8M55,901.34%333.69M138.02%38.16M-3,861.45%-63.5M320.27%109.43M72.08%-7.17M97.44%-598K-100.36M-1.6M
Net issuance payments of debt -101.47%-1.56M--025,839.26%450.44M492.21%37.75M-3,528.57%-63.5M305.80%106.5M-107.25%-3.5M60.00%-1.75M---9.63M---1.75M
Net common stock issuance --0----------0--0--0-----------75M--0
Proceeds from stock option exercised by employees 7.51%3.09M105.64%207K-365.41%-5.35M2.82%7.21M3,667.92%5.99M38.29%2.88M-267.29%-3.67M-22.08%2.02M--7.02M--159K
Net other financing activities -375.93%-149K-120.00%-11K-12,808.11%-111.4M70.09%-6.81M-49,841.67%-5.99M700.00%54K99.56%-5K96.01%-863K---22.76M---12K
Cash from discontinued financing activities
Financing cash flow -98.74%1.38M-943.00%-74.8M55,901.34%333.69M138.02%38.16M-3,861.45%-63.5M320.27%109.43M72.08%-7.17M97.44%-598K---100.36M---1.6M
Net cash flow
Beginning cash position -14.74%299.28M20.55%344.43M-37.15%178.8M9.62%284.47M-13.40%193.98M45.52%351.01M32.92%285.72M9.62%284.47M--259.5M--224M
Current changes in cash 117.35%27.78M-173.86%-49.35M5,077.38%167.07M-454.53%-102.48M-120.79%-12.48M-635.35%-160.05M120.63%66.82M108.15%3.23M--28.91M--60M
Effect of exchange rate changes -305.63%-6.21M374.46%4.2M26.80%-1.45M19.08%-3.19M-684.63%-2.7M-33.85%3.02M62.04%-1.53M59.98%-1.97M---3.94M--462K
End cash Position 65.40%320.85M-14.74%299.28M20.55%344.43M-37.15%178.8M-37.15%178.8M-13.40%193.98M45.52%351.01M32.92%285.72M--284.47M--284.47M
Free cash flow 331.92%35.22M-56.24%39.39M-390.02%-33.08M-29.11%115.46M-56.83%29.23M-131.93%-15.19M76.21%90.01M428.30%11.41M--162.87M--67.69M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!